Export 87 results:
Filters: First Letter Of Last Name is K  [Clear All Filters]
P
DuPont, H. L., Formal S. B., Hornick R. B., Snyder M. J., Libonati J. P., Sheahan D. G., et al. (1971).  Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285, 1.
DuPont, H. L., Formal S. B., Hornick R. B., Snyder M. J., Libonati J. P., Sheahan D. G., et al. (1971).  Pathogenesis of Escherichia coli Diarrhea. New England Journal of Medicine. 285, 1–9.
Publisher: Massachusetts Medical Society
Kaper, J. B., Nataro J. P., & Mobley H. L. (2004).  Pathogenic Escherichia coli. Nature Reviews. 2, 123-140.
Kaper, J.. B., Nataro J.. P., & Mobley H.. L. (2004).  Pathogenic Escherichia coli. Nature Reviews. Microbiology.. 2, 123-140.
Kaper, J.. B., Nataro J.. P., & Mobley H.. L. (2004).  Pathogenic Escherichia coli. Nature Reviews. Microbiology.. 2, 123-140.
Mika, K. Beth, Imamura G., Chang C., Conway V., Fernandez G., Griffith J. F., et al. (2009).  Pilot-and bench-scale testing of faecal indicator bacteria survival in marine beach sand near point sources. Journal of applied microbiology. 107, 72–84.
Altboum, Z., Gozes Y., Barnea A., Pass A., White M., & Kobiler D. (2002).  Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs. Infection and immunity. 70, 6231–6241.
Altboum, Z.., Gozes Y.., Barnea A.., Pass A.., White M.., & Kobiler D.. (2002).  Postexposure prophylaxis against anthrax: Evaluation of various treatment regimes in intranasally infected guinea pigs. Infection and Immunity. 70, 6231-6241.
Altboum, Z.., Gozes Y.., Barnea A.., Pass A.., White M.., & Kobiler D.. (2002).  Postexposure Prophylaxis against Anthrax: Evaluation of Various Treatment Regimens in Intranasally Infected Guinea Pigs. Infection and Immunity. 70, 11.
Kay, D., Jones F., Wyer MD., Fleisher JM., Salmon RL., Godfree AF., et al. (1994).  Predicting likelihood of gastroenteritis from sea bathing: results from randomised exposure. The lancet. 344, 905–909.
Couch, R.. B., Cate T.. R., Gerone P.. J., Fleet W.. F., Lang D.. J., Griffith W.. R., et al. (1965).  Production of Illness with a Small-Particle Aerosol of Coxsackie A21*. Journal of Clinical Investigation. 44, 4.
Kerr, K.G.., & Snelling A.M.. (2009).  Pseudomonas aeruignosa: a formidable and ever-present adversary. Journal of Hospital Infection. 73, 338 - 344.
R
Canter, D. A., Gunning D., Rodgers P., O'connor L., Traunero C., & Kempter C. J. (2005).  Remediation of Bacillus anthracis contamination in the US Department of Justice mail facility. Biosecurity and bioterrorism: biodefense strategy, practice, and science. 3, 119–127.
Parrott, R.. H., Kim H.. W., Brandt C.. D., & Chanock R.. M. (1974).  Respiratory syncytial virus in infants and children. Preventive medicine. 3, 4.
Louie, J. K., Yagi S., Nelson F. A., Kiang D., Glaser C. A., Rosenberg J., et al. (2005).  Rhinovirus Outbreak in a Long Term Care Facility for Elderly Persons Associated with Unusually High Mortality. CID. 41, 262-265.
Weiss, E.., & Moulder J.. W. (1984).  The rickettsias and chlamydias. (Kreig, N.. R., & Holt J.. G., Ed.).Bergey's manual of systematic bacteriology. 687-739.
Nam, S.. U. K. U., , , , , , et al. (2011).  Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia. Scandinavian Journal of Infectious Diseases. 43, 792.
Kaplowitz, L.. G., Fischer J.. J., & Sparling P.. F. (1981).  Rocky Mountain spotted fever: a clinical dilemma. Curr. Clin. Top. Infect. Dis. 2, 89-108.
Donnenberg, M.. S., Tacket C.. O., James S.. P., Losonsky G.., Nataro J.. P., Wasserman S.. S., et al. (1993).  Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92, 3.